Scott Reisman

Scott Reisman has a diverse work experience spanning over multiple companies and roles. Scott currently holds the position of Senior Director and Head of Toxicology at Disc Medicine since April 2022. Prior to this, they worked at Reata Pharmaceuticals, Inc. for over a decade, starting in 2009. During their time at Reata Pharmaceuticals, they held various positions such as Director of Nonclinical Development, Associate Director of Nonclinical, Senior Principal Scientist in Early Development, Principal Scientist in Early Development, and Senior Analyst and Analyst in Product Development. Before joining Reata Pharmaceuticals, Scott was a Graduate Student at the University of Kansas Medical Center from 2004 to 2008.

Scott Reisman received their B.S. degree in Chemistry from Rockhurst University, where they studied from 1999 to 2002. Scott then pursued a Ph.D. in Toxicology at the University of Kansas Medical Center from 2004 to 2008. There is no information available regarding any additional certifications they may have obtained.